Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.72 +0.33 (+1.35%)
Streaming Delayed Price Updated: 10:27 AM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Where Will Pfizer Be in 3 Years?
Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very complicated. 
Via The Motley Fool
Topics Intellectual Property
Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs. 
Via The Motley Fool
Shutdown Deal Breathes New Life Into Wall Street
The prospect of a quick end to the US government shutdown has rekindled investor confidence. Tech rebounds, semiconductors sprint ahead, and insurers feel political pressure building. Meanwhile, all... 
Via Chartmill
Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring
Pfizer not only beat expectations last quarter, but also boosted its guidance. 
Via The Motley Fool
Topics Earnings Intellectual Property
Pfizer CEO Reportedly Drops F-Bomb On Live TV Discussing Seagen, Metsera Deals
Via Stocktwits
The Top 5 Analyst Questions From Pfizer’s Q3 Earnings Call
Pfizer’s third quarter results reflected ongoing challenges in its COVID-19 franchise, but management pointed to solid growth in non-COVID products and disciplined cost management as key drivers of... 
Via StockStory
Topics Earnings
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Looking for the most active stocks in the S&P500 index on Monday?
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
These stocks are the most active in today's session
Monday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity! 
Via Chartmill
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable... 
Via TokenRing AI
Topics Artificial Intelligence
Market Resilience Tested: How Investors Can Navigate U.S. Government Shutdowns
As the U.S. political landscape continues to present its unique set of challenges, the specter of a government shutdown remains a perennial concern for investors. These periods, marked by a cessation... 
Via MarketMinute
Topics Bonds Economy Government
Wall Street Cheers as Senate Vote Signals End to Record-Breaking US Government Impasse
Global equity markets have surged in early November 2025, fueled by renewed optimism that the United States government's historic shutdown, which commenced on October 1, 2025, may finally be nearing... 
Via MarketMinute
Topics Economy Workforce
Cogent Biosciences' Lead Cancer Drug Cuts Disease Progression Or Death Risk By 50% In Stomach Cancer Trial
Cogent Biosciences stock rises as bezuclastinib plus Sutent shows 50% lower progression risk and strong efficacy in Phase 3 GIST trial. 
Via Benzinga
Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion
The final bid, at $10 billion, is expected to wrap up after Nov. 13 with the next shareholders' vote. 
Via Investor's Business Daily
Topics Initial Public Offering
Markets Breathe Sigh of Relief as Historic Government Shutdown Nears Resolution
Washington D.C. – November 10, 2025 – The United States stock market is experiencing a significant uplift today, as news of an impending resolution to the nation's longest-ever government shutdown... 
Via MarketMinute
Topics Economy Government
Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith
Novo investors on Stocktwits praised new CEO Mike Doustdar as “dynamic,” saying they remain confident in Novo’s long-term obesity and diabetes pipeline despite short-term setbacks. 
Via Stocktwits
Market Reels from Volatility and Mixed Signals: A Deep Dive into Investor Unease
The past week, from November 1st to November 8th, 2025, has witnessed a significant shift in global market sentiment, moving decisively towards a "risk-off" stance. Investors are grappling with... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
2 No-Brainer Dividend Stocks to Buy With $100 in November
There's no need to break the bank to get your hands on excellent dividend payers. 
Via The Motley Fool
Topics Economy World Trade
Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors.
Weight loss drugs generated about $10 billion for Lilly in the most recent quarter. 
Via The Motley Fool
Topics Government
Global Virtual Summit Puts the Spotlight on Sickle Cell Caregivers
November 8, 2025 -- Four-Day Event Unites Families, Advocates, and Medical Experts to Prioritize Mental Wellness, Advocacy, and Legacy 
Via 24-7 Press Release
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Nvidia CEO Jensen Huang cautioned Elon Musk against underestimating the challenges of semiconductor manufacturing, saying building a chip fab like TSMC's is "extremely hard." 
Via Benzinga
Deal Dispatch: From A Founder Comeback To Billion-Dollar Bids, This Week In M&A And Bankruptcy
 
Via Benzinga
Why Novo Nordisk Stock Is Sinking This Week
The global drugmaker is facing some headwinds related to tough competition. 
Via The Motley Fool
Topics Government World Trade
The Stock Market Is Signaling a Recession. Here's How to Prepare Your Portfolio.
The financial markets are increasingly flashing warning signs that an economic recession may be on the horizon, prompting investors to re-evaluate their strategies. A confluence of indicators, from... 
Via MarketMinute
Topics Bonds Economy Stocks
Friday's session: most active stock in the S&P500 index
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements. 
Via Chartmill
Tech Sell-Off Rocks Wall Street: Nasdaq, S&P 500, and Dow Sink Amidst Brutal Week for Stocks
New York, NY – November 7, 2025 – The U.S. stock market has been gripped by a significant downturn in early November 2025, culminating in a brutal week that saw the Nasdaq Composite, S&P 500, and Dow... 
Via MarketMinute
Topics Artificial Intelligence Economy Retirement
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
The feast that saw obesity-tied stocks skyrocket in 2024 is over. Investors' appetite for weight-loss drugs has waned. 
Via Investor's Business Daily
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.